Overview

Prevention of Arrhythmia Device Infection Trial (PADIT)

Status:
Completed
Trial end date:
2017-09-08
Target enrollment:
Participant gender:
Summary
The goal of the study is to compare whether a center-wide policy of incremental antibiotic therapy will reduce CIED infection rate compared to a policy of conventional antibiotic prophylaxis in high-risk patients undergoing arrhythmia device procedures. All antibiotics used are approved for use and readily available.
Phase:
Phase 4
Details
Lead Sponsor:
Population Health Research Institute
Collaborator:
Canadian Institutes of Health Research (CIHR)
Treatments:
Anti-Bacterial Agents
Bacitracin
Cefazolin
Cephalexin
Vancomycin